Published in AIDS Weekly, July 27th, 1998
A Japanese study suggests that the intranasal route of vaccine administration may offer superior efficacy in such a vaccine ("Induction of Systemic and Mucosal Immune Responses to HIV-1 by a DNA Vaccine Formulated with QS-21 Saponin Adjuvant Via Intramuscular and Intranasal Routes," Journal of Virology, June 1998;72(6):4931-4939).
In this study, S. Sasaki and colleagues compared intramuscular and intranasal immunizations...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.